Molecular analysis of etiological factors and malignant degrees for non-small cell lung cancer
Molecular analysis of etiological factors and malignant degrees for non-small cell lung cancer
批准号:
15590327
负责人:
TSUCHIYA Eiju
金额:
$2.11万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
74 resected squamous cell carcinomas (sqs) and 239 adenocarcinomas were analyzed for p53 mutation : Any relationships between tumor location of sqs or subtype of adenocarcinomas, smoking, and p53 mutation patterns were then examined focusing on varying etiological factors. Our hypothesis was, that G→T transversion of p53 gene is caused by direct action of carcinogens contained in tobacco smoke on DNA, and that G→A transition at CpG (CpG→A) sites of the gene is caused by endogenous mechanisms. The same adenocarcinoma cases were also analyzed to determine what type of combined mutation status on p53 and k-ras affects malignancy of the tumors more strongly.Results:1) Sqs were divided into three types by location - central, intermediate and periphera l; the highest frequencies of CpG→A in the central type, G→T in the intermediate and other mutations in the peripheral, were observed. 2)Adenocarcinomas were divided into five types - hobnail, columnar, goblet, polygonal and mixed. Of these, the hobnail type showed a low p53 mutation frequency with the highest CpG→A rate, the columnar and polygonal types had a high mutation frequency with the highest G→T rates, and the mixed type showed intermediate frequency of p53 with the highest other base change. 3)Five year survival was the highest for adenocarcinomas with the combination of non-mutated p53 and k-ras, followed by the combination of mutated p53 and non-mutated k-ras, and then the combination of non-mutated p53 and mutated k-ras, with the combination of mutated p53 and k-ras having the lowest survival.The results show that etiological factors vary depending on locations of sqs and subtype of adenocarcinomas ; the worst malignancy was adenocarcinomas with the combined status on mutated p53 and k-ras.
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/j.1349-7006.2004.tb03212.x
发表时间:
2004-04
期刊:
Cancer Science
影响因子:
5.7
作者:
[Yasuhito Kobayashi;Y. Tokuchi;T. Hashimoto;M. Hayashi;H. Nishimura;Y. Ishikawa;K. Nakagawa;Y. Sato;Atsushi Takahashi;E. Tsuchiya]
通讯作者:
Yasuhito Kobayashi;Y. Tokuchi;T. Hashimoto;M. Hayashi;H. Nishimura;Y. Ishikawa;K. Nakagawa;Y. Sato;Atsushi Takahashi;E. Tsuchiya
DOI:
10.1002/ijc.21877
发表时间:
2006-08
期刊:
International Journal of Cancer
影响因子:
6.4
作者:
[Takuo Shimmyo;T. Hashimoto;Yasuhito Kobayashi;Y. Miyagi;Y. Ishikawa;K. Nakagawa;H. Osada;E. Tsuchiya]
通讯作者:
Takuo Shimmyo;T. Hashimoto;Yasuhito Kobayashi;Y. Miyagi;Y. Ishikawa;K. Nakagawa;H. Osada;E. Tsuchiya
肺癌、病理診断に役立つ分子病理学・10、シリーズ最新医学講座・II.
对肺癌病理诊断有用的分子病理学/10,最新医学课程系列/II.
DOI:
--
发表时间:
2004
期刊:
臨床検査 48
影响因子:
--
作者:
[石川雄一, 土屋永寿]
通讯作者:
土屋永寿
DOI:
10.1158/1078-0432.ccr-04-1436
发表时间:
2004-12-15
期刊:
CLINICAL CANCER RESEARCH
影响因子:
11.5
作者:
[Ishikawa, N, Daigo, Y, Nakamura, Y]
通讯作者:
Nakamura, Y
Kobayashi K, Tokuchi Y, Hashimoto T.M Tsuchiva E.et al.: "Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors"Cancer Science. (in press).
Kobayashi K、Tokuchi Y、Hashimoto T.M Tsuchiva E.等人:“用于强化神经内分泌肺肿瘤组织学亚分类的分子标记”癌症科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 8 条
Prediction of therapy effects and cancer susceptibility for lung cancers by combined data of histology, polymorphism and gene alterations
-
批准号:18590358
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.71万
-
财政年份:2006
-
负责人:TSUCHIYA Eiju
-
依托单位:
海外基金